112 related articles for article (PubMed ID: 33713944)
1. Prognostic value of FUS immunoexpression for Gleason patterns and prostatic adenocarcinoma progression.
Hirth CG; Vasconcelos GR; Lima MVA; da Cunha MDPSS; Frederico IKS; Dornelas CA
Ann Diagn Pathol; 2021 Jun; 52():151729. PubMed ID: 33713944
[TBL] [Abstract][Full Text] [Related]
2. High Gleason grade carcinoma at a positive surgical margin predicts biochemical failure after radical prostatectomy and may guide adjuvant radiotherapy.
Savdie R; Horvath LG; Benito RP; Rasiah KK; Haynes AM; Chatfield M; Stricker PD; Turner JJ; Delprado W; Henshall SM; Sutherland RL; Kench JG
BJU Int; 2012 Jun; 109(12):1794-800. PubMed ID: 21992536
[TBL] [Abstract][Full Text] [Related]
3. Prognostic Value of Percent Gleason Grade 4 at Prostate Biopsy in Predicting Prostatectomy Pathology and Recurrence.
Cole AI; Morgan TM; Spratt DE; Palapattu GS; He C; Tomlins SA; Weizer AZ; Feng FY; Wu A; Siddiqui J; Chinnaiyan AM; Montgomery JS; Kunju LP; Miller DC; Hollenbeck BK; Wei JT; Mehra R
J Urol; 2016 Aug; 196(2):405-11. PubMed ID: 26920466
[TBL] [Abstract][Full Text] [Related]
4. Immunoexpression of HSPA9 and CUL2 in prostatic tissue and adenocarcinoma.
Hirth CG; Vasconcelos GR; da Cunha MDPSS; Leite CHB; Dornelas CA
Ann Diagn Pathol; 2022 Feb; 56():151843. PubMed ID: 34717191
[TBL] [Abstract][Full Text] [Related]
5. Adenocarcinoma on needle prostatic biopsies: does reactive stroma predicts biochemical recurrence in patients following radical prostatectomy?
Billis A; Meirelles L; Freitas LL; Polidoro AS; Fernandes HA; Padilha MM; Magna LA; Reis LO; Ferreira U
Int Braz J Urol; 2013; 39(3):320-7. PubMed ID: 23849565
[TBL] [Abstract][Full Text] [Related]
6. Impact of positive surgical margins on prostate-specific antigen failure after radical prostatectomy in adjuvant treatment-naïve patients.
Ploussard G; Agamy MA; Alenda O; Allory Y; Mouracade P; Vordos D; Hoznek A; Abbou CC; de la Taille A; Salomon L
BJU Int; 2011 Jun; 107(11):1748-54. PubMed ID: 20883488
[TBL] [Abstract][Full Text] [Related]
7. Presence of high grade tertiary Gleason pattern upgrades the Gleason sum score and is inversely associated with biochemical recurrence-free survival.
Turker P; Bas E; Bozkurt S; Günlüsoy B; Sezgin A; Postacı H; Turkeri L
Urol Oncol; 2013 Jan; 31(1):93-8. PubMed ID: 21316989
[TBL] [Abstract][Full Text] [Related]
8. Gleason pattern 5 is the strongest pathologic predictor of recurrence, metastasis, and prostate cancer-specific death in patients receiving salvage radiation therapy following radical prostatectomy.
Jackson W; Hamstra DA; Johnson S; Zhou J; Foster B; Foster C; Li D; Song Y; Palapattu GS; Kunju LP; Mehra R; Feng FY
Cancer; 2013 Sep; 119(18):3287-94. PubMed ID: 23821578
[TBL] [Abstract][Full Text] [Related]
9. Impact of Gleason pattern 5 including tertiary pattern 5 on outcomes of salvage treatment for biochemical recurrence in pT2-3N0M0 prostate cancer.
Taguchi S; Shiraishi K; Fukuhara H; Nakagawa K; Morikawa T; Naito A; Kakutani S; Takeshima Y; Miyazaki H; Nakagawa T; Fujimura T; Kume H; Homma Y
Int J Clin Oncol; 2016 Oct; 21(5):975-980. PubMed ID: 27098807
[TBL] [Abstract][Full Text] [Related]
10. Integrating Tertiary Gleason 5 Patterns into Quantitative Gleason Grading in Prostate Biopsies and Prostatectomy Specimens.
Sauter G; Clauditz T; Steurer S; Wittmer C; Büscheck F; Krech T; Lutz F; Lennartz M; Harms L; Lawrenz L; Möller-Koop C; Simon R; Jacobsen F; Wilczak W; Minner S; Tsourlakis MC; Chirico V; Weidemann S; Haese A; Steuber T; Salomon G; Matiu M; Vettorazzi E; Michl U; Budäus L; Tilki D; Thederan I; Pehrke D; Beyer B; Fraune C; Göbel C; Heinrich M; Juhnke M; Möller K; Bawahab AAA; Uhlig R; Huland H; Heinzer H; Graefen M; Schlomm T
Eur Urol; 2018 May; 73(5):674-683. PubMed ID: 28117112
[TBL] [Abstract][Full Text] [Related]
11. Impact of a tertiary Gleason pattern 4 or 5 on clinical failure and mortality after radical prostatectomy for clinically localised prostate cancer.
Servoll E; Saeter T; Vlatkovic L; Lund T; Nesland J; Waaler G; Axcrona K; Beisland HO
BJU Int; 2012 May; 109(10):1489-94. PubMed ID: 21933333
[TBL] [Abstract][Full Text] [Related]
12. SOCS3 Immunohistochemical Expression Seems to Support the 2005 and 2014 International Society of Urological Pathology (ISUP) Modified Gleason Grading System.
Pierconti F; Martini M; Cenci T; Petrone GL; Ricci R; Sacco E; Bassi PF; Larocca LM
Prostate; 2017 May; 77(6):597-603. PubMed ID: 28144985
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of architectural subtypes of Gleason grade 4 prostate cancer in radical prostatectomy: A semiquantitative method of evaluation.
da Paz AR; Billis A; Freitas LLL; Costa LBE; Barreto IS; Magna LA; Matheus WE; Ferreira U
Ann Diagn Pathol; 2021 Feb; 50():151678. PubMed ID: 33341702
[TBL] [Abstract][Full Text] [Related]
14. The Gleason score of tumor at the margin in radical prostatectomy is predictive of biochemical recurrence.
Cao D; Kibel AS; Gao F; Tao Y; Humphrey PA
Am J Surg Pathol; 2010 Jul; 34(7):994-1001. PubMed ID: 20505501
[TBL] [Abstract][Full Text] [Related]
15. Tertiary Gleason pattern 5 is a powerful predictor of biochemical relapse in patients with Gleason score 7 prostatic adenocarcinoma.
Hattab EM; Koch MO; Eble JN; Lin H; Cheng L
J Urol; 2006 May; 175(5):1695-9; discussion 1699. PubMed ID: 16600733
[TBL] [Abstract][Full Text] [Related]
16. The Impact of Downgrading from Biopsy Gleason 7 to Prostatectomy Gleason 6 on Biochemical Recurrence and Prostate Cancer Specific Mortality.
Ham WS; Chalfin HJ; Feng Z; Trock BJ; Epstein JI; Cheung C; Humphreys E; Partin AW; Han M
J Urol; 2017 Apr; 197(4):1060-1067. PubMed ID: 27847296
[TBL] [Abstract][Full Text] [Related]
17. Prognostic influence of the third Gleason grade in prostatectomy specimens.
Cedeño Díaz OM; Fernández Aceñero MJ; Alvarez Fernández E
Urol Oncol; 2012; 30(4):386-90. PubMed ID: 21292510
[TBL] [Abstract][Full Text] [Related]
18. Histologic Grading of Prostatic Adenocarcinoma Can Be Further Optimized: Analysis of the Relative Prognostic Strength of Individual Architectural Patterns in 1275 Patients From the Canary Retrospective Cohort.
McKenney JK; Wei W; Hawley S; Auman H; Newcomb LF; Boyer HD; Fazli L; Simko J; Hurtado-Coll A; Troyer DA; Tretiakova MS; Vakar-Lopez F; Carroll PR; Cooperberg MR; Gleave ME; Lance RS; Lin DW; Nelson PS; Thompson IM; True LD; Feng Z; Brooks JD
Am J Surg Pathol; 2016 Nov; 40(11):1439-1456. PubMed ID: 27635949
[TBL] [Abstract][Full Text] [Related]
19. The significance of micro-lymphatic invasion and pathological Gleason score in prostate cancer patients with pathologically organ-confined disease and negative surgical margins after robot-assisted radical prostatectomy.
Hashimoto T; Nakashima J; Inoue R; Komori O; Yamaguchi Y; Kashima T; Satake N; Nakagami Y; Namiki K; Nagao T; Ohno Y
Int J Clin Oncol; 2020 Feb; 25(2):377-383. PubMed ID: 31673831
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of Aquaporin-1 is a Prognostic Factor for Biochemical Recurrence in Prostate Adenocarcinoma.
Park JY; Yoon G
Pathol Oncol Res; 2017 Jan; 23(1):189-196. PubMed ID: 27817002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
